Gene Symbol | Gene ID | Gene Info |
---|---|---|
Atf3
|
ENSMUSG00000026628.8 | activating transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_191178657_191178808 | Atf3 | 4376 | 0.155340 | -0.32 | 1.1e-02 | Click! |
chr1_191182017_191182176 | Atf3 | 1012 | 0.443813 | 0.19 | 1.5e-01 | Click! |
chr1_191186422_191186579 | Atf3 | 3160 | 0.180271 | 0.16 | 2.3e-01 | Click! |
chr1_191216235_191216677 | Atf3 | 1583 | 0.290867 | -0.13 | 3.3e-01 | Click! |
chr1_191193662_191194196 | Atf3 | 10589 | 0.132549 | -0.11 | 3.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_19082814_19086200 | 6.63 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr1_118481967_118482873 | 5.07 |
Clasp1 |
CLIP associating protein 1 |
381 |
0.8 |
chr5_125056018_125058841 | 4.70 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr1_51288641_51290950 | 4.70 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr5_139796771_139798844 | 4.28 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
293 |
0.85 |
chr9_44486015_44488913 | 4.21 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr18_65083730_65084940 | 3.91 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
1281 |
0.54 |
chr6_55336550_55338274 | 3.86 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr5_35727822_35729089 | 3.85 |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
557 |
0.73 |
chr6_112459682_112460792 | 3.85 |
Cav3 |
caveolin 3 |
732 |
0.65 |
chr8_45887181_45888227 | 3.76 |
Pdlim3 |
PDZ and LIM domain 3 |
2184 |
0.22 |
chr6_115984719_115988278 | 3.72 |
Plxnd1 |
plexin D1 |
8507 |
0.15 |
chr2_32095529_32096644 | 3.62 |
Plpp7 |
phospholipid phosphatase 7 (inactive) |
69 |
0.95 |
chr7_142474634_142476734 | 3.50 |
Lsp1 |
lymphocyte specific 1 |
690 |
0.52 |
chr5_113137768_113139144 | 3.49 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
470 |
0.68 |
chr13_103095440_103095946 | 3.40 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
1135 |
0.63 |
chr11_43834010_43835381 | 3.37 |
Adra1b |
adrenergic receptor, alpha 1b |
1637 |
0.47 |
chr3_79887847_79889192 | 3.34 |
Gm36569 |
predicted gene, 36569 |
1713 |
0.31 |
chr7_101394207_101396000 | 3.27 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
448 |
0.73 |
chr14_34375555_34377243 | 3.26 |
Mmrn2 |
multimerin 2 |
678 |
0.52 |
chr6_24599228_24599578 | 3.25 |
Lmod2 |
leiomodin 2 (cardiac) |
1641 |
0.31 |
chr3_129331827_129332986 | 3.21 |
Enpep |
glutamyl aminopeptidase |
142 |
0.95 |
chr13_74362852_74363978 | 3.20 |
Lrrc14b |
leucine rich repeat containing 14B |
590 |
0.54 |
chr15_99248527_99250738 | 3.18 |
1700120C14Rik |
RIKEN cDNA 1700120C14 gene |
121 |
0.74 |
chr17_25077528_25081106 | 3.15 |
Tmem204 |
transmembrane protein 204 |
1093 |
0.35 |
chr11_3504385_3504832 | 3.12 |
Inpp5j |
inositol polyphosphate 5-phosphatase J |
163 |
0.9 |
chr19_5724785_5726881 | 3.11 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr2_152931122_152933148 | 3.02 |
Foxs1 |
forkhead box S1 |
1073 |
0.38 |
chr2_114051146_114052179 | 3.01 |
Actc1 |
actin, alpha, cardiac muscle 1 |
1225 |
0.4 |
chr6_53573075_53574499 | 3.00 |
Creb5 |
cAMP responsive element binding protein 5 |
411 |
0.9 |
chr10_80584595_80587584 | 2.95 |
Abhd17a |
abhydrolase domain containing 17A |
535 |
0.53 |
chr10_14017752_14018957 | 2.89 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
51330 |
0.13 |
chr7_45920062_45921322 | 2.88 |
Emp3 |
epithelial membrane protein 3 |
159 |
0.87 |
chr10_58394296_58394848 | 2.87 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
184 |
0.95 |
chr3_96560509_96561681 | 2.87 |
Txnip |
thioredoxin interacting protein |
1041 |
0.27 |
chr14_54991806_54993467 | 2.84 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1055 |
0.25 |
chr9_56866808_56868850 | 2.83 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
2796 |
0.18 |
chr6_119194389_119194967 | 2.78 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
1553 |
0.37 |
chr11_116105976_116108472 | 2.77 |
Trim47 |
tripartite motif-containing 47 |
141 |
0.91 |
chr19_36118883_36119585 | 2.76 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
676 |
0.71 |
chr8_104101710_104103631 | 2.76 |
Cdh5 |
cadherin 5 |
1045 |
0.43 |
chr9_21196536_21198489 | 2.75 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr5_24995023_24996226 | 2.75 |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
129 |
0.96 |
chr8_48511120_48511677 | 2.74 |
Tenm3 |
teneurin transmembrane protein 3 |
43915 |
0.19 |
chr11_116108498_116109194 | 2.70 |
Trim47 |
tripartite motif-containing 47 |
727 |
0.48 |
chr3_128520016_128520866 | 2.67 |
Gm22293 |
predicted gene, 22293 |
19931 |
0.25 |
chr3_57292810_57293244 | 2.67 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
676 |
0.7 |
chr15_102102931_102104191 | 2.67 |
Tns2 |
tensin 2 |
573 |
0.62 |
chr14_54988853_54989389 | 2.62 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1703 |
0.14 |
chr1_135840170_135841177 | 2.62 |
Tnnt2 |
troponin T2, cardiac |
26 |
0.97 |
chr4_118488976_118489210 | 2.59 |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
662 |
0.54 |
chr3_19647711_19647862 | 2.58 |
Trim55 |
tripartite motif-containing 55 |
3278 |
0.2 |
chr18_11057575_11058184 | 2.58 |
Gata6 |
GATA binding protein 6 |
1168 |
0.53 |
chr1_172501767_172503923 | 2.56 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr14_103469521_103469981 | 2.55 |
Gm34907 |
predicted gene, 34907 |
5700 |
0.22 |
chr9_56864653_56866648 | 2.54 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
617 |
0.51 |
chr9_107975554_107976970 | 2.54 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr11_104578496_104579513 | 2.53 |
Myl4 |
myosin, light polypeptide 4 |
1321 |
0.29 |
chr1_135803358_135803785 | 2.48 |
Tnni1 |
troponin I, skeletal, slow 1 |
1486 |
0.32 |
chr10_108434849_108435510 | 2.48 |
Gm36283 |
predicted gene, 36283 |
1486 |
0.41 |
chr14_31209518_31210345 | 2.44 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
1599 |
0.22 |
chr14_63268302_63270010 | 2.41 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr2_91118182_91118787 | 2.39 |
Mybpc3 |
myosin binding protein C, cardiac |
340 |
0.81 |
chr6_116651389_116652299 | 2.39 |
Depp1 |
DEPP1 autophagy regulator |
1148 |
0.32 |
chr2_32646588_32647989 | 2.38 |
Eng |
endoglin |
295 |
0.76 |
chr10_63457257_63458786 | 2.38 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr1_34122909_34123345 | 2.38 |
Dst |
dystonin |
1877 |
0.31 |
chr11_59138017_59138780 | 2.37 |
Obscn |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
772 |
0.52 |
chr4_140580764_140581885 | 2.36 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
478 |
0.83 |
chr6_119195676_119196202 | 2.36 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
292 |
0.91 |
chr16_35157395_35159144 | 2.35 |
Adcy5 |
adenylate cyclase 5 |
3392 |
0.29 |
chr6_112273463_112275203 | 2.34 |
Lmcd1 |
LIM and cysteine-rich domains 1 |
575 |
0.71 |
chr6_85371815_85372854 | 2.34 |
Rab11fip5 |
RAB11 family interacting protein 5 (class I) |
2230 |
0.24 |
chr6_24599678_24600100 | 2.34 |
Lmod2 |
leiomodin 2 (cardiac) |
2127 |
0.25 |
chr4_8237536_8238080 | 2.31 |
Car8 |
carbonic anhydrase 8 |
1233 |
0.46 |
chr4_64045430_64045799 | 2.29 |
Tnc |
tenascin C |
1401 |
0.48 |
chr1_135799428_135800706 | 2.28 |
Tnni1 |
troponin I, skeletal, slow 1 |
234 |
0.9 |
chr2_17460205_17460550 | 2.28 |
Nebl |
nebulette |
244 |
0.96 |
chr10_75589353_75590449 | 2.28 |
Ggt5 |
gamma-glutamyltransferase 5 |
109 |
0.89 |
chr16_32660648_32662499 | 2.26 |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
321 |
0.85 |
chr5_32713090_32713944 | 2.24 |
Gm43852 |
predicted gene 43852 |
471 |
0.7 |
chr10_127749619_127751660 | 2.23 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr18_62176067_62177775 | 2.21 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr1_51294105_51294669 | 2.19 |
Cavin2 |
caveolae associated 2 |
5261 |
0.21 |
chr2_73003682_73004722 | 2.18 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
16961 |
0.14 |
chr17_81737002_81738450 | 2.18 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr17_28007198_28009699 | 2.18 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr4_123564242_123564871 | 2.18 |
Macf1 |
microtubule-actin crosslinking factor 1 |
138 |
0.96 |
chr3_138067510_138069146 | 2.18 |
Gm5105 |
predicted gene 5105 |
940 |
0.46 |
chr14_63242982_63243456 | 2.17 |
Gata4 |
GATA binding protein 4 |
2029 |
0.3 |
chr3_138064815_138065971 | 2.15 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
341 |
0.81 |
chr1_134802830_134803774 | 2.15 |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
549 |
0.61 |
chr15_41867093_41867460 | 2.14 |
Abra |
actin-binding Rho activating protein |
2444 |
0.29 |
chr12_52854803_52855496 | 2.14 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
59313 |
0.14 |
chr1_164454554_164455430 | 2.14 |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
1215 |
0.39 |
chr4_109155589_109157355 | 2.13 |
Osbpl9 |
oxysterol binding protein-like 9 |
138 |
0.97 |
chr19_58413288_58413588 | 2.12 |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
41028 |
0.17 |
chr2_26583920_26584875 | 2.12 |
Egfl7 |
EGF-like domain 7 |
492 |
0.6 |
chr15_77021062_77022444 | 2.11 |
Mb |
myoglobin |
210 |
0.89 |
chr16_11985754_11986188 | 2.08 |
Shisa9 |
shisa family member 9 |
1251 |
0.58 |
chr11_115899671_115901427 | 2.05 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr8_128361057_128361799 | 2.04 |
Nrp1 |
neuropilin 1 |
2031 |
0.32 |
chr13_46422196_46422985 | 2.04 |
Rbm24 |
RNA binding motif protein 24 |
768 |
0.72 |
chr2_114048711_114048862 | 2.03 |
Actc1 |
actin, alpha, cardiac muscle 1 |
4101 |
0.19 |
chr18_3280827_3281518 | 2.03 |
Crem |
cAMP responsive element modulator |
40 |
0.98 |
chr16_50689551_50689950 | 2.03 |
Gm9575 |
predicted gene 9575 |
23404 |
0.17 |
chr16_97534630_97535746 | 2.02 |
Mx2 |
MX dynamin-like GTPase 2 |
120 |
0.95 |
chr1_97975537_97975875 | 2.02 |
Pam |
peptidylglycine alpha-amidating monooxygenase |
1362 |
0.45 |
chr17_24643558_24645911 | 2.02 |
Slc9a3r2 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 |
223 |
0.82 |
chrX_140956935_140957373 | 2.02 |
Atg4a |
autophagy related 4A, cysteine peptidase |
204 |
0.73 |
chr3_79885722_79887545 | 2.02 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr10_81424113_81425703 | 2.02 |
Nfic |
nuclear factor I/C |
2206 |
0.11 |
chr1_51291546_51292409 | 2.01 |
Cavin2 |
caveolae associated 2 |
2851 |
0.27 |
chr5_112894973_112895548 | 2.01 |
Myo18b |
myosin XVIIIb |
1102 |
0.54 |
chr5_115908055_115909691 | 2.00 |
Cit |
citron |
1403 |
0.37 |
chr17_3397051_3398448 | 1.99 |
Tiam2 |
T cell lymphoma invasion and metastasis 2 |
519 |
0.8 |
chr9_24768577_24769049 | 1.99 |
Tbx20 |
T-box 20 |
867 |
0.6 |
chr5_115433807_115437237 | 1.99 |
Msi1 |
musashi RNA-binding protein 1 |
24 |
0.93 |
chr16_95454656_95455466 | 1.97 |
Erg |
ETS transcription factor |
4184 |
0.32 |
chr15_81936444_81938042 | 1.97 |
Csdc2 |
cold shock domain containing C2, RNA binding |
261 |
0.82 |
chr10_38966776_38966927 | 1.96 |
Lama4 |
laminin, alpha 4 |
1179 |
0.56 |
chr9_79875436_79876355 | 1.95 |
Gm3211 |
predicted gene 3211 |
37305 |
0.12 |
chr15_98775840_98778905 | 1.95 |
Wnt10b |
wingless-type MMTV integration site family, member 10B |
111 |
0.92 |
chr2_124612015_124613212 | 1.95 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
2012 |
0.47 |
chr12_15811126_15812067 | 1.94 |
Trib2 |
tribbles pseudokinase 2 |
5189 |
0.17 |
chr5_75577269_75578512 | 1.93 |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
2935 |
0.29 |
chr8_12926230_12928559 | 1.93 |
Mcf2l |
mcf.2 transforming sequence-like |
762 |
0.52 |
chr3_116805825_116806207 | 1.93 |
Agl |
amylo-1,6-glucosidase, 4-alpha-glucanotransferase |
1401 |
0.31 |
chr2_155611238_155612364 | 1.92 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
589 |
0.53 |
chrX_152178908_152179528 | 1.92 |
Iqsec2 |
IQ motif and Sec7 domain 2 |
254 |
0.93 |
chr14_34587287_34588669 | 1.90 |
Ldb3 |
LIM domain binding 3 |
503 |
0.69 |
chr3_116968200_116969270 | 1.89 |
Palmd |
palmdelphin |
8 |
0.89 |
chr9_96752202_96752827 | 1.89 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
171 |
0.94 |
chr18_40258245_40258964 | 1.89 |
Gm31087 |
predicted gene, 31087 |
109 |
0.63 |
chr11_106713611_106714349 | 1.88 |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
966 |
0.48 |
chr13_113013114_113013713 | 1.87 |
Mcidas |
multiciliate differentiation and DNA synthesis associated cell cycle protein |
19568 |
0.08 |
chr9_121950447_121951756 | 1.87 |
Gask1a |
golgi associated kinase 1A |
66 |
0.94 |
chr18_39483580_39484106 | 1.86 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
3389 |
0.32 |
chr11_101965649_101967097 | 1.86 |
Sost |
sclerostin |
642 |
0.52 |
chr8_14683396_14684419 | 1.86 |
Dlgap2 |
DLG associated protein 2 |
58846 |
0.13 |
chr9_79976568_79977294 | 1.85 |
Filip1 |
filamin A interacting protein 1 |
728 |
0.66 |
chr2_32081622_32082932 | 1.85 |
Fam78a |
family with sequence similarity 78, member A |
1506 |
0.26 |
chr12_24680420_24681760 | 1.85 |
Cys1 |
cystin 1 |
67 |
0.96 |
chr6_144779851_144780433 | 1.84 |
Sox5 |
SRY (sex determining region Y)-box 5 |
1777 |
0.35 |
chr19_29271229_29271592 | 1.84 |
Jak2 |
Janus kinase 2 |
18969 |
0.16 |
chr5_119972869_119973766 | 1.84 |
Gm38554 |
predicted gene, 38554 |
14074 |
0.21 |
chr14_54962885_54964094 | 1.83 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
3085 |
0.08 |
chr9_56090050_56091507 | 1.81 |
Pstpip1 |
proline-serine-threonine phosphatase-interacting protein 1 |
802 |
0.62 |
chr10_40737288_40738233 | 1.81 |
Mettl24 |
methyltransferase like 24 |
54478 |
0.13 |
chr3_123033789_123034940 | 1.80 |
Myoz2 |
myozenin 2 |
480 |
0.73 |
chr4_94739067_94739954 | 1.79 |
Tek |
TEK receptor tyrosine kinase |
8 |
0.98 |
chr4_57569383_57569972 | 1.79 |
Pakap |
paralemmin A kinase anchor protein |
1347 |
0.55 |
chr2_70083482_70084035 | 1.79 |
Myo3b |
myosin IIIB |
684 |
0.74 |
chr2_91119045_91119896 | 1.79 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr14_36918744_36919600 | 1.77 |
Ccser2 |
coiled-coil serine rich 2 |
161 |
0.97 |
chr15_40167738_40168248 | 1.77 |
Gm33301 |
predicted gene, 33301 |
5386 |
0.2 |
chr9_77344436_77344707 | 1.75 |
Mlip |
muscular LMNA-interacting protein |
3222 |
0.21 |
chr9_50752994_50754649 | 1.75 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr19_53793697_53793977 | 1.75 |
Rbm20 |
RNA binding motif protein 20 |
529 |
0.76 |
chr13_5865166_5866516 | 1.74 |
Klf6 |
Kruppel-like factor 6 |
1163 |
0.44 |
chr16_95703800_95705386 | 1.74 |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
1746 |
0.39 |
chr9_50751156_50752468 | 1.74 |
Cryab |
crystallin, alpha B |
65 |
0.86 |
chr5_57723598_57724600 | 1.74 |
Gm42635 |
predicted gene 42635 |
294 |
0.83 |
chr16_38366176_38366327 | 1.74 |
Popdc2 |
popeye domain containing 2 |
2559 |
0.18 |
chr9_79975154_79975866 | 1.74 |
Filip1 |
filamin A interacting protein 1 |
2149 |
0.3 |
chr17_26507015_26507427 | 1.74 |
Dusp1 |
dual specificity phosphatase 1 |
502 |
0.67 |
chr18_60963604_60964955 | 1.73 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
679 |
0.59 |
chr11_65266805_65267363 | 1.73 |
Myocd |
myocardin |
2770 |
0.29 |
chr6_121299940_121301268 | 1.73 |
Slc6a13 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 |
178 |
0.93 |
chr13_49308099_49309227 | 1.73 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
577 |
0.76 |
chr17_72921491_72924008 | 1.72 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr8_61900565_61900716 | 1.72 |
Palld |
palladin, cytoskeletal associated protein |
2029 |
0.29 |
chr5_74676974_74677904 | 1.72 |
Lnx1 |
ligand of numb-protein X 1 |
190 |
0.94 |
chr10_80314572_80317647 | 1.71 |
2310011J03Rik |
RIKEN cDNA 2310011J03 gene |
4428 |
0.07 |
chr8_69887012_69889642 | 1.71 |
Yjefn3 |
YjeF N-terminal domain containing 3 |
142 |
0.84 |
chr6_88200114_88201718 | 1.71 |
Gata2 |
GATA binding protein 2 |
3 |
0.96 |
chr1_164455819_164456603 | 1.71 |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
1811 |
0.27 |
chr13_103109833_103110089 | 1.71 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
13116 |
0.26 |
chr2_158145151_158146425 | 1.71 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr18_80258361_80258974 | 1.70 |
Slc66a2 |
solute carrier family 66 member 2 |
2349 |
0.18 |
chr9_109058757_109059725 | 1.70 |
Trex1 |
three prime repair exonuclease 1 |
10 |
0.93 |
chr10_127643084_127644231 | 1.70 |
Stat6 |
signal transducer and activator of transcription 6 |
655 |
0.49 |
chr2_173024069_173026002 | 1.69 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr9_101198368_101199080 | 1.69 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
127 |
0.94 |
chr11_121014589_121015240 | 1.69 |
Gm11774 |
predicted gene 11774 |
11130 |
0.09 |
chr7_46097834_46098538 | 1.68 |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
240 |
0.86 |
chr4_62620787_62622274 | 1.68 |
Rgs3 |
regulator of G-protein signaling 3 |
1948 |
0.3 |
chr1_131278585_131279837 | 1.68 |
Ikbke |
inhibitor of kappaB kinase epsilon |
395 |
0.77 |
chr19_53793336_53793637 | 1.67 |
Rbm20 |
RNA binding motif protein 20 |
178 |
0.94 |
chr6_23180015_23180259 | 1.67 |
Gm5301 |
predicted pseudogene 5301 |
12723 |
0.13 |
chr4_86885709_86886839 | 1.67 |
Acer2 |
alkaline ceramidase 2 |
11860 |
0.21 |
chr5_80706733_80706963 | 1.66 |
Gm22974 |
predicted gene, 22974 |
186806 |
0.03 |
chr2_180388160_180389480 | 1.66 |
Mir1a-1 |
microRNA 1a-1 |
228 |
0.89 |
chr2_112267547_112267881 | 1.65 |
Slc12a6 |
solute carrier family 12, member 6 |
895 |
0.38 |
chr6_55338294_55340060 | 1.65 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr6_83179353_83180686 | 1.64 |
Dctn1 |
dynactin 1 |
406 |
0.67 |
chr18_61659524_61661310 | 1.64 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
5073 |
0.12 |
chr3_138066011_138066302 | 1.64 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
1104 |
0.33 |
chr19_5691875_5693863 | 1.64 |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
26 |
0.92 |
chr2_148441004_148443557 | 1.64 |
Cd93 |
CD93 antigen |
1283 |
0.41 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.8 | 8.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.7 | 8.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.5 | 7.5 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.1 | 6.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.9 | 7.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.9 | 7.5 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.6 | 4.9 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.6 | 6.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.5 | 4.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.5 | 13.7 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.4 | 4.3 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.4 | 4.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.4 | 4.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.3 | 2.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.3 | 5.2 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.3 | 1.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.3 | 5.1 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
1.3 | 5.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.2 | 6.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.2 | 3.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.2 | 4.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.2 | 1.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.1 | 1.1 | GO:0030239 | myofibril assembly(GO:0030239) |
1.1 | 5.5 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
1.0 | 1.0 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.0 | 4.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.0 | 4.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.0 | 3.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.0 | 1.9 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.0 | 3.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 3.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 0.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.9 | 2.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 3.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.9 | 2.7 | GO:0003032 | detection of oxygen(GO:0003032) |
0.9 | 6.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.9 | 2.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.9 | 0.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.9 | 2.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.8 | 2.5 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.8 | 3.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.8 | 5.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 2.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 2.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.8 | 1.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 4.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.8 | 7.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.8 | 1.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.8 | 2.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.7 | 1.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 1.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 1.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.7 | 4.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.7 | 0.7 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.7 | 2.8 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.7 | 3.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.7 | 3.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.7 | 2.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.7 | 2.7 | GO:0050904 | diapedesis(GO:0050904) |
0.7 | 2.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 4.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.7 | 1.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 1.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 1.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 2.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.6 | 1.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 2.5 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.6 | 2.5 | GO:0035482 | gastric motility(GO:0035482) |
0.6 | 1.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 1.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.6 | 4.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.6 | 1.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.6 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.6 | 0.6 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.6 | 1.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 1.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.6 | 2.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 0.6 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.6 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 2.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.6 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.6 | 1.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.6 | 0.6 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.5 | 1.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.5 | 2.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 0.5 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.5 | 1.6 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.5 | 1.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.5 | 1.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 1.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.5 | 1.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 2.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 1.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 0.5 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 0.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 1.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.5 | 2.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 8.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 | 4.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 1.5 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 1.0 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.5 | 1.5 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.5 | 1.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 1.5 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 1.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 4.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 0.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 1.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 2.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.5 | 2.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.5 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 2.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.5 | 1.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 0.5 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.5 | 0.5 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.5 | 2.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 1.4 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.5 | 2.4 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.5 | 1.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 1.9 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.5 | 1.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 1.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 3.8 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 0.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 2.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 1.4 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.5 | 1.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 0.5 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.5 | 3.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 0.5 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.5 | 3.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 1.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 1.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 5.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.5 | 1.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 1.8 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 1.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 1.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 2.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 1.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 0.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 0.9 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.4 | 3.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 1.8 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.4 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 9.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 2.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.4 | 1.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.4 | 3.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 1.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.4 | 2.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 1.7 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.4 | 1.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 0.8 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.4 | 1.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 3.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 0.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 0.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.4 | 4.1 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 0.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 2.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 1.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 2.8 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.4 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 0.8 | GO:0032762 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
0.4 | 2.0 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 1.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 7.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 3.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.4 | 0.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 1.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 2.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 2.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.4 | 1.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 1.2 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 3.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.4 | 1.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.4 | 0.4 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.4 | 1.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 0.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 0.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 2.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 1.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 1.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 1.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.4 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 0.7 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.4 | 1.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.4 | 2.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 1.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 1.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.4 | 1.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 1.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.4 | 1.8 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.4 | 1.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 0.4 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.4 | 1.1 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.4 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 2.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 0.7 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.4 | 1.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 0.7 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 2.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 1.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 1.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 1.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 1.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 1.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 0.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.3 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 2.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 0.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 2.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 0.3 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.3 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 1.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 2.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 1.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 0.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 1.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.3 | 0.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.3 | 0.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 3.6 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 3.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 2.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 1.6 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 3.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 2.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 1.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 2.6 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 2.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.3 | 0.3 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.3 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 3.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 0.6 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 1.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 0.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 1.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.9 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 0.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 1.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 1.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 1.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 1.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 0.3 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.3 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.9 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.3 | 0.3 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.3 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.9 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 1.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 3.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 1.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.3 | 0.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 3.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 0.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.3 | 0.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 1.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 2.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 0.6 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.9 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 5.6 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 2.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 2.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.3 | 1.4 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 0.9 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 1.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.6 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.4 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.3 | 2.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.1 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 1.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 1.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 1.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.3 | 0.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 1.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 8.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 0.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 0.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 6.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.1 | GO:0046959 | habituation(GO:0046959) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 2.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 1.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 1.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.8 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 1.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 0.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.8 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.3 | 0.3 | GO:0003161 | cardiac conduction system development(GO:0003161) sinoatrial node development(GO:0003163) |
0.3 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.8 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.8 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.3 | 2.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 2.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 0.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 0.8 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 0.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 0.8 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 2.1 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 1.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 2.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 2.0 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 1.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 1.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 1.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.3 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.7 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 1.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 1.0 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 1.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.5 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 2.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.5 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 3.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 1.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 1.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 1.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.7 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.2 | 1.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 2.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 2.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.5 | GO:0097178 | ruffle assembly(GO:0097178) |
0.2 | 0.7 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.7 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 0.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 1.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 2.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 1.8 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.2 | GO:0072683 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) |
0.2 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.5 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 4.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 1.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.4 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.2 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.7 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 3.4 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 1.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.7 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 0.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 1.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 2.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 1.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 1.1 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.2 | 0.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 1.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 0.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 0.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 2.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.2 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.2 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 0.2 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.2 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 1.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 0.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 1.3 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.2 | 0.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.2 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.2 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 4.0 | GO:0051196 | regulation of coenzyme metabolic process(GO:0051196) |
0.2 | 0.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.2 | 1.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 1.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 3.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.8 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 0.2 | GO:1903115 | regulation of actin filament-based movement(GO:1903115) |
0.2 | 0.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 2.4 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.8 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.2 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.2 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 0.8 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 0.4 | GO:0051133 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.2 | 0.8 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.2 | 0.6 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.6 | GO:0003307 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.2 | 0.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.2 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.6 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 1.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.2 | 1.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.6 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.2 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.2 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.2 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.6 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 2.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 0.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 1.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 5.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.5 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.2 | 0.5 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.6 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.5 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.9 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 1.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.7 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.3 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 2.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.7 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.5 | GO:0097531 | mast cell migration(GO:0097531) |
0.2 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 1.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.3 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 1.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 1.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.3 | GO:0002477 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.2 | 1.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.2 | 0.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 2.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.6 | GO:0015677 | copper ion import(GO:0015677) ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 1.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 0.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.2 | 0.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 2.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 3.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 0.2 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.2 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 1.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 1.8 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.7 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 1.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.4 | GO:0006203 | dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.1 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.6 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 1.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 2.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.4 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.1 | GO:0045054 | multivesicular body organization(GO:0036257) constitutive secretory pathway(GO:0045054) |
0.1 | 0.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 2.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 1.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.7 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 1.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 1.2 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.1 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.9 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 1.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.4 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.5 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 1.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 2.0 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 1.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 1.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.1 | 0.5 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 1.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.4 | GO:0003097 | renal water transport(GO:0003097) |
0.1 | 1.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.5 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.4 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.2 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.6 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 1.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.2 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 2.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.9 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.9 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.2 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 1.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 1.4 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.4 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.1 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 10.4 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 0.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 1.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 2.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.2 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 0.3 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.8 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.1 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 2.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
0.1 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 1.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 1.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.9 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.9 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.1 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.4 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 2.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.8 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 1.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 1.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.4 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.1 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 1.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.6 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.1 | 0.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 2.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.2 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 1.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 1.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.7 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.1 | 0.4 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.6 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 2.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 1.0 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.1 | 0.2 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 2.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.2 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 1.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 1.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.1 | 0.3 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.8 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 1.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 4.3 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.1 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 2.3 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 4.1 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 1.6 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0001994 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.1 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.1 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.2 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.4 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.1 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 9.1 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.3 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.3 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.2 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.4 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.8 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.9 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 1.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 2.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.4 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.0 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 1.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 1.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.0 | 0.2 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.5 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.0 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.0 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.4 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.0 | 0.0 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.0 | 0.7 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.0 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.1 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound metabolic process(GO:0052803) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0003157 | endocardium development(GO:0003157) |
0.0 | 0.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.3 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.0 | 0.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 0.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.1 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.4 | 7.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.6 | 4.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.6 | 9.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.5 | 9.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.4 | 4.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.4 | 10.9 | GO:0005861 | troponin complex(GO:0005861) |
1.3 | 4.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.1 | 3.2 | GO:0097443 | sorting endosome(GO:0097443) |
1.0 | 2.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 5.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 3.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 8.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.8 | 9.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 2.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 3.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 2.6 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 3.1 | GO:0097433 | dense body(GO:0097433) |
0.6 | 2.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 3.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 5.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 1.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 23.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.6 | 15.9 | GO:0031672 | A band(GO:0031672) |
0.5 | 3.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 60.1 | GO:0030016 | myofibril(GO:0030016) |
0.5 | 3.8 | GO:0043292 | contractile fiber(GO:0043292) |
0.5 | 1.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.5 | 1.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 2.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 2.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 9.3 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 2.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 2.8 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 2.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.4 | 2.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 0.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.4 | 1.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 4.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 2.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 2.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 2.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 5.4 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 1.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 2.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 5.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.9 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 11.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 5.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 2.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 4.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 2.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 3.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 14.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.5 | GO:0005912 | adherens junction(GO:0005912) |
0.2 | 1.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 13.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 3.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.9 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 2.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.4 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 3.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 7.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.2 | 5.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.6 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 2.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 2.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.7 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 2.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 3.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 3.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 3.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 0.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 2.4 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 1.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 0.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 3.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 3.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.6 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 12.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 3.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 2.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 3.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 5.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 1.0 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.8 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 1.9 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 1.0 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 6.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 5.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 5.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 8.9 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.0 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.7 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 7.3 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 2.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 1.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 4.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 4.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 6.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.2 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 17.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 4.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 5.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.4 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 5.8 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 4.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 22.0 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 3.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 3.3 | GO:0044437 | vacuolar part(GO:0044437) |
0.1 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 4.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.7 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 52.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 2.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 8.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 3.9 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 1.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 14.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 27.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.6 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 2.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 2.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.9 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.0 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 41.0 | GO:0016020 | membrane(GO:0016020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.3 | GO:0031433 | telethonin binding(GO:0031433) |
2.0 | 6.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.9 | 5.6 | GO:0030172 | troponin C binding(GO:0030172) |
1.7 | 8.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.7 | 1.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.7 | 11.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.6 | 6.4 | GO:0043515 | kinetochore binding(GO:0043515) |
1.5 | 4.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.5 | 4.4 | GO:0070538 | oleic acid binding(GO:0070538) |
1.5 | 4.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.3 | 3.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.1 | 9.6 | GO:0031432 | titin binding(GO:0031432) |
1.1 | 3.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.0 | 3.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 3.0 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 2.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.0 | 3.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.9 | 12.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 1.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.9 | 0.9 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.9 | 4.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 4.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.8 | 1.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 3.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 6.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.7 | 1.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.7 | 18.2 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.7 | 5.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.7 | 2.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 2.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 2.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.7 | 4.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 1.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 2.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 3.3 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 2.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 6.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 1.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 1.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.6 | 0.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 1.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 1.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.6 | 3.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 0.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.6 | 2.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 1.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.6 | 1.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 1.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 1.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 1.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 2.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 2.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 6.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 1.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 1.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.5 | 1.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 2.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 1.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 1.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 2.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 5.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 4.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 1.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 1.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 2.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 2.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 1.8 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 0.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 8.4 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 2.2 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 8.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 4.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 2.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 2.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 1.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 2.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 2.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 0.4 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.4 | 1.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 2.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 2.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 2.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 0.4 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.4 | 2.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 1.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 1.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 2.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 1.1 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 1.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 1.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 2.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 1.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 3.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 2.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 1.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 1.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 3.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 1.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 2.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 2.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 3.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 3.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 2.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 1.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 1.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 3.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 2.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 4.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 2.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 2.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 1.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 6.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 3.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 1.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 2.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 3.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 2.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 2.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 1.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 1.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.3 | 2.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 1.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 1.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 1.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 2.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 4.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 2.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 3.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 5.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 2.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 1.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 0.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 3.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 1.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 3.0 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 4.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 17.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 1.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.5 | GO:0018633 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 1.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 23.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 2.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 1.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 5.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 0.9 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 1.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 2.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 2.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.4 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.2 | 0.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 3.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 2.8 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.9 | GO:0034943 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 1.5 | GO:0052669 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.2 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 2.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 1.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.2 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 3.9 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 1.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 2.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 2.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 1.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 3.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 2.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 2.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 4.8 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 4.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 2.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 9.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 2.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 35.4 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 3.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 2.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 4.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 4.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 24.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.8 | GO:0052849 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 2.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 3.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 2.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 2.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.4 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 3.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 2.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 2.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0008443 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.5 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 5.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 2.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.1 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.9 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 1.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 2.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 4.6 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 2.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 2.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) guanylyltransferase activity(GO:0070568) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 1.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 5.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 1.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 1.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 1.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 1.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 5.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 3.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 2.5 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 26.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.3 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 1.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 2.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.7 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 1.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.8 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 1.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 1.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 2.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 4.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 1.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 10.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.5 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 1.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 1.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.3 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.7 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 23.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 19.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 4.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 1.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 3.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 4.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 14.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 1.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 8.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 7.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 4.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 10.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 5.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 8.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 6.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 2.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 1.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 3.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 3.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 2.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 2.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 4.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 2.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 4.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 2.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 6.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 2.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 8.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 3.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 8.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 6.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 2.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 3.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 5.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 3.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 1.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 10.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 2.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 5.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 4.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 2.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 5.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 2.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 1.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 2.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 7.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 4.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 2.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 26.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 9.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 9.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 4.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 9.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.4 | 9.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 5.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 3.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 1.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.4 | 2.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 3.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 6.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 2.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 4.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 3.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 38.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 3.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 6.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 2.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 3.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 11.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 3.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 7.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 3.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 1.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 3.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 2.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 4.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 2.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 3.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 3.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 2.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.3 | 1.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 3.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 2.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 3.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 6.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 2.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 1.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 17.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 10.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 3.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 9.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 7.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 6.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 3.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 4.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 1.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 2.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 6.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 2.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 1.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 2.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 3.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 0.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 0.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 4.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 2.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 4.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 6.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 5.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 8.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 3.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 12.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 3.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 2.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 3.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.3 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.1 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 1.7 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 3.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 2.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.7 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.0 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |